Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography – Global Forecast to 2021 to 2026

$3,850.00$5,850.00

Published on: March 24, 2021
Clear
SKU: GMS-3108 Category:

OVERVIEW

The Global Radioimmunoassay Market is expected to hit USD 1.34 billion by 2026, rising at a CAGR of 3.4 percent from 2021 to 2026, owing to the COVID-19 pandemic. Market growth is expected to be aided by factors such as increasing cancer and infectious disease prevalence and incidence, as well as technological advancements. The effect of COVID-19 on the market for the years 2020 and beyond is detailed in the report.

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 1

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 2

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 3

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 4

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 5

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 6

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 7

Radioimmunoassay Market by Application (Clinical Diagnostics, Hospital, Pharmaceutical Industry), Type (Analyzers, Reagents & Kits), End User (Academics, Clinical Diagnostic Labs, Hospital, Pharmaceutical Industry) and Geography - Global Forecast to 2021 to 2026 8

TABLE OF CONTENT

1 Global Radioimmunoassay Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Radioimmunoassay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Radioimmunoassay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Radioimmunoassay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Radioimmunoassay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Radioimmunoassay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Radioimmunoassay Market – By Type (Market Size – & million/billion)
8.1 Analyzers
8.2 Reagents & Kits Market

9 Global Radioimmunoassay Market – By Application
9.1 Research
9.2 Clinical Diagnostics

10 Global Radioimmunoassay Market – By End-User
10.1 Hospital
10.2 Academics
10.3 Pharmaceutical Industry and CRO
10.4 Clinical Diagnostic Laboratories

11 Global Radioimmunoassay Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Radioimmunoassay Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Radioimmunoassay Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Diasorin S.P.A.
13.3 Merck Millipore Corporation
13.4 Izotop
13.5 MP Biomedicals LLC
13.6 Diasource Immunossays S.A
13.7 Beckman Coulter, Inc.
13.8 Euro Diagnostica AB
13.9 Cisbio
13.10 Stratec Biomedicals AG
13.11 Perkinelmer, Inc.
13.12 Company 11 & more

14 Global Radioimmunoassay Market – Appendix
14.1 Sources
14.2 Abbreviations